UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000036373
Receipt number R000041438
Scientific Title Immunoglobulin correlates with the severity in septic patients
Date of disclosure of the study information 2019/06/01
Last modified on 2020/04/01 09:12:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Immunoglobulin correlates with the severity in septic patients

Acronym

Correlation between immunoglobulin and severity of sepsis

Scientific Title

Immunoglobulin correlates with the severity in septic patients

Scientific Title:Acronym

Correlation between immunoglobulin and severity of sepsis

Region

Japan


Condition

Condition

Infection disease/ Sepsis

Classification by specialty

Emergency medicine Intensive care medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Analysis of correlation between the level of serum Ig and the severity in infection disease and sepsis

Basic objectives2

Others

Basic objectives -Others

Analysis of correlation between the level of serum Ig and rapid turnover protein in infection disease and sepsis

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

severity score(SOFA score)

Key secondary outcomes

rapid turnover protein


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

>17 years, hospitalized patients caused by infection

Key exclusion criteria

<18 years

Target sample size

300


Research contact person

Name of lead principal investigator

1st name Shinji
Middle name
Last name Ogura

Organization

Gifu University Graduate School of Medicine

Division name

Department of emergency and disaster medicine

Zip code

501-1194

Address

1-1 Yanagido, Gifu, Japan

TEL

058-230-6448

Email

oguras@gifu-u.ac.jp


Public contact

Name of contact person

1st name Hideshi
Middle name
Last name Okada

Organization

Gifu University Graduate School of Medicine

Division name

Department of emergency and disaster medicine

Zip code

5011194

Address

1-1 Yanagido, Gifu, Japan

TEL

058-230-6448

Homepage URL


Email

hideshi@gifu-u.ac.jp


Sponsor or person

Institute

Department of emergency and disaster medicine, Gifu University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Department of emergency and disaster medicine, Gifu University Graduate School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Institutional Review Board for Clinical Research of Gifu University

Address

1-1 Yanagido, Gifu 501-1194, Japan

Tel

058-230-6059

Email

rinri@gifu-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 06 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2016 Year 02 Month 06 Day

Date of IRB

2016 Year 03 Month 02 Day

Anticipated trial start date

2016 Year 03 Month 10 Day

Last follow-up date

2019 Year 06 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

We analize the correlation between the level of serum Ig and severity in infection disease or/and septic patients enrolled between January 2008 and December 2015 retrospectively.


Management information

Registered date

2019 Year 04 Month 01 Day

Last modified on

2020 Year 04 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041438


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name